Obesity Linked to Increased Risk for Progression to T2D in Children
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 18, 2023 -- For children with prediabetes, factors associated with an increased risk for progression to type 2 diabetes (T2D) include obesity, according to a study published online Oct. 12 in the Journal of the Endocrine Society.
Natasha Belsky, from Vanderbilt University School of Medicine in Nashville, Tennessee, and colleagues conducted a retrospective chart review of a pediatric prediabetes clinic. Data were included for 552 patients; during 2.4 ± 1.5 years, 6.5 percent progressed to T2D.
The researchers found that T2D progressors had a higher body mass index, hemoglobin A1c (HbA1c), two-hour glucose, and C-peptide at the initial visit. No significant difference was seen in fasting glucose. Male sex, initial visit HbA1c, and two-hour glucose level were all predictive of T2D progression in a multivariable model (hazard ratios, 2.4, 1.3 per 0.1 percent, and 1.2 per 10-mg/dL increase). An increase in body mass index of 4.2 kg/m2 was seen for patients who progressed to T2D, while children consistently taking metformin took longer to progress.
"This is a real-world study that highlights ways to identify the children at highest risk for diabetes and possible strategies for diabetes prevention in children such as treatment with antidiabetes or antiobesity medications," coauthor Ashley H. Shoemaker, M.D., also from Vanderbilt University, said in a statement. "Our study found patients who were on metformin had lower blood sugar levels and were slower to progress to diabetes."
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Small Differences in Weight Change With First-Line Antidepressants
MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study...
American Diabetes Association, June 21-24
The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world...
Few With Type 2 Diabetes Receive Guideline-Recommended CKD Screening
MONDAY, July 1, 2024 -- Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.